About the Hub

Molecular Imaging Research drives the development of innovative radiopharmaceuticals for positron emission tomographic (PET) imaging for diagnostic and potentially therapeutic (theranostics) purposes. The research focuses on the development of new, more efficient methods for producing existing radioactive drugs in the cyclotron facility.


photo of Kiel Neumann
Kiel D. Neumann, PhD

Director, Molecular Imaging Research Hub